Literature DB >> 16195525

A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders.

Judith R Baker1, Sally O Crudder, Brenda Riske, Val Bias, Ann Forsberg.   

Abstract

People with rare, inherited chronic health conditions, such as hemophilia, face added physical, social, emotional, and fiscal challenges beyond those that are common to more prevalent chronic conditions. In 1975, a partnership among clinicians, consumers, and government agencies created a nationwide regional health delivery system that increased access to clinical care, prevention, and research, thereby improving health outcomes for people with hemophilia in the United States. Today, more than 130 Comprehensive Hemophilia Diagnostic and Treatment Centers in 12 regions serve 70%-80% of the nation's hemophilia patients. Health care leaders and advocates for other rare, expensive, chronic disorders may find that regionalization improves survival and reduces disability among affected populations. However, diverse and stable resources are needed to sustain such a model in our profit-oriented US health care arena.

Entities:  

Mesh:

Year:  2005        PMID: 16195525      PMCID: PMC1449458          DOI: 10.2105/AJPH.2004.051318

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  27 in total

1.  Guam's quest for improved hemophilia care.

Authors:  Roselie V Zabala; Judith R Baker
Journal:  Pac Health Dialog       Date:  2002-09

2.  Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits.

Authors:  R S Zeiger; S Heller; M H Mellon; J Wald; R Falkoff; M Schatz
Journal:  J Allergy Clin Immunol       Date:  1991-06       Impact factor: 10.793

3.  Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.

Authors:  B L Evatt; E D Gomperts; J S McDougal; R B Ramsey
Journal:  N Engl J Med       Date:  1985-02-21       Impact factor: 91.245

4.  Frequency of inherited bleeding disorders in women with menorrhagia.

Authors:  R A Kadir; D L Economides; C A Sabin; D Owens; C A Lee
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival.

Authors:  M M Kitahata; T D Koepsell; R A Deyo; C L Maxwell; W T Dodge; E H Wagner
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

6.  Results of a program to reduce admissions for adult asthma.

Authors:  P H Mayo; J Richman; H W Harris
Journal:  Ann Intern Med       Date:  1990-06-01       Impact factor: 25.391

7.  The benefits of comprehensive care of hemophilia: a five-year study of outcomes.

Authors:  P S Smith; P H Levine
Journal:  Am J Public Health       Date:  1984-06       Impact factor: 9.308

8.  AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use.

Authors:  B J Turner; L McKee; T Fanning; L E Markson
Journal:  Med Care       Date:  1994-09       Impact factor: 2.983

Review 9.  Comprehensive care for haemophilia around the world.

Authors:  B L Evatt; C Black; A Batorova; A Street; A Srivastava
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

10.  Hepatitis A virus infections associated with clotting factor concentrate in the United States.

Authors:  J M Soucie; B H Robertson; B P Bell; K A McCaustland; B L Evatt
Journal:  Transfusion       Date:  1998-06       Impact factor: 3.157

View more
  22 in total

1.  Public health surveillance and data collection: general principles and impact on hemophilia care.

Authors:  J Michael Soucie
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

2.  The U.S. Thrombosis and Hemostasis Centers pilot sites program.

Authors:  N F Dowling; M G Beckman; M Manco-Johnson; K Hassell; C S Philipp; L A Michaels; S Moll; J A Heit; J Penner; R Kulkarni; S Pipe; P Bockenstedt; J Andersen; S Crudder; A H James; S Zimmerman; T L Ortel
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

3.  Birth defects and disabilities: a public health issue for the 21st century.

Authors:  Coleen A Boyle; José F Cordero
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

Review 4.  Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors:  Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Philosophy of care delivery for spina bifida.

Authors:  Judy Thibadeau; William O Walker; Jonathan Castillo; Brad E Dicianno; Jonathan C Routh; Kathryn A Smith; Lijing Ouyang
Journal:  Disabil Health J       Date:  2019-12-20       Impact factor: 2.554

Review 6.  Current and evolving features in the clinical management of haemophilia.

Authors:  Antonio Coppola; Massimo Morfini; Ernesto Cimino; Antonella Tufano; Anna M Cerbone; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

7.  Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease.

Authors:  Timothy L McCavit; Hua Lin; Song Zhang; Chul Ahn; Charles T Quinn; Glenn Flores
Journal:  Am J Hematol       Date:  2011-04       Impact factor: 10.047

Review 8.  Reducing Health Care Disparities in Sickle Cell Disease: A Review.

Authors:  LaTasha Lee; Kim Smith-Whitley; Sonja Banks; Gary Puckrein
Journal:  Public Health Rep       Date:  2019-10-10       Impact factor: 2.792

9.  Men with severe hemophilia in the United States: birth cohort analysis of a large national database.

Authors:  Marshall A Mazepa; Paul E Monahan; Judith R Baker; Brenda K Riske; J Michael Soucie
Journal:  Blood       Date:  2016-03-16       Impact factor: 22.113

10.  Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.

Authors:  Julie A Wolfson; Can-Lan Sun; Laura P Wyatt; Arti Hurria; Smita Bhatia
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.